The global cardiovascular information system (CVIS) market is expected to reach USD 1.2 billion by 2024, according to a new report by Grand View Research Inc. The global cardiovascular devices industry is growing swiftly owing to the increasing prevalence of heart diseases and other cardiovascular problems.
In accordance with the growing patient population there is an exponential surge in the patient history documents and patient data records. The resultant,rising burden of patient data is pushing forward the demand for effective management tools; thus, offering increased accessibility of patient information to surgeons and the healthcare staff and hence enhancing the operational efficiency of the practices. In addition, factors, such as technological advancements and the gradually growing awareness regarding the availability of these improved systems are expected to fuel the growth of the cardiovascular devices market.
However, factors,such as high system costs and the lack of skilled operators are impeding the overall growth. In addition, the presence of alternative data management tools is challenging the adoption of the information systems specific to cardiovascular data management. Some of the key players in the market are implementing strategies to expand market share. For instance, companies, such as Philips Healthcare and GE Healthcare offer CVIS systems along with their cardiac imaging products.
Further Key Findings from the Study Suggest:
The CVIS segment captured the largest market share of the global market in 2015. Integration of these systems with imaging devices is responsible for the highest adoption rate of this segment.
Owing to the high cost of these systems, the CVIS segment is expected to maintain its dominance during the forecast period
The cloud-based segment is anticipated to exhibit the fastest growth rate during the forecast period. The associated advantages, such as the affordable cost, remote accessibility of data, and the user friendly interface, are expected to fuel the adoption of the cloud-based mode of operation.
North America capturedthe largest market share of around 36% in 2015. The dominance of the segment is expected to continue with a CAGR of 5.8% from 2016 to 2024.
The factors contributing to the growth of the North America market include the increasing prevalence of heart diseases and the technological advancements in the region. Moreover, factors, such as the availability of highly advanced healthcare facilities and the higher adoption rate of the data management tools are augmenting the market growth in North America.
Asia Pacific is anticipated to grow at the fastest rate during the forecast period. Countries, such as India and China are expected to be the fastest growing markets in the region owing to the large pool of cardiovascular patients and the rising healthcare expenditure.
The booming medical tourism in Asia Pacific due to the availability of advanced healthcare facilities and services at a lower cost in comparison to the other developed countries serves as the pivotal factor in attracting cardiac patients worldwide to this region.
Some major players in this market include Philips Healthcare, GE Healthcare, McKesson Corporation, Siemens Healthcare GmbH, Merge Healthcare, Inc., Agfa Healthcare N.V., Cerner Corporation, Fujifilm Medical Systems, Inc., Lumedx Corporation, and Digisonics, Inc.
Our reports have been used by over 10K customers, including:
The global medical tourism market is expected to exhibit strong growth during 2021-2026. Medical tourism refers to organized travel across countries to receive medical treatment. It usually involves traveling abroad for maintenance, enhancement or restoration of health through advanced healthcare facilities and treatment...
The Middle East and Africa cardiac rehabilitation market is expected to reach US$ 90.26 million by 2028 from US$ 59.97 million in 2020; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028. The growth of the market is attributed to key driving factors such as growing adoption of tele-cardiac rehabilitation and supportive government...
This IDC report highlights the necessity for healthcare providers to adopt an electronic medical record (EMR) system, especially with the acceleration of digital health after the COVID-19 pandemic. The report analyzes various government drives toward EMR adoption in Asia/Pacific along with regulations and policies in place. Specific case examples...
The global generic oncology drugs market exhibited strong growth during 2015-2020. Generic oncology drugs assist in shrinking, controlling and destroying the cancer cells present in the human body. Furthermore, a few oncology drugs are widely prescribed by doctors to alleviate symptoms, including pain. They share the...
This report focuses on types of healthcare information technology such as electronic health records, provider order entry systems, electronic prescribing systems, picture archiving and communication systems, laboratory information systems, clinical decision systems, and telemedicine.The report covers the market...
This IDC study discusses how healthcare organizations are on a mission to digitally transform to create a value-based healthcare system, even though they may not use the term digital transformation as extensively as other industries such as retail or financial services do. While the pandemic drove unprecedented adoption of virtual visits and...
The global fertility services market exhibited strong growth during 2015-2020. Fertility services refer to the procedures provided as a treatment for infertility. Infertility is defined as the inability to conceive or carry a full-term pregnancy. Among males, it is identified by a low sperm count or is a result of hormonal...
Hip Replacement Market, Global Forecast, Impact of Coronavirus, Industry Trends, Growth, Opportunity By Products, Regions, Company Analysis Hip replacement is a minimally invasive surgical procedure to replace a hip joint with a prosthetic implant. It is a general surgery that helps to minimize pain...
The Asia Pacific cardiac rehabilitation market is expected to reach US$ 566.21 million by 2028 from US$ 357.64 million in 2021; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as rise in technologically advanced cardiac rehabilitation products and supportive...
The North America cardiac rehabilitation market is expected to reach US$ 1,258.21 million by 2028 from US$ 809.40 million in 2021; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The growth of the market is attributed to key driving factors such as rising incidences of cardiovascular diseases, and growing adoption of tele-cardiac...
Cause-Specific Mortality Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.